Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Podholding is a life sciences company primarily known for its innovative PODS (Protein On Delivery System) technology, which provides a platform for the sustained release of therapeutic proteins. The company focuses on developing advanced medical solutions, particularly in the fields of wound care and regenerative medicine. Its flagship products utilize micro-encapsulated proteins to enhance healing processes in chronic conditions such as diabetic foot ulcers. By stabilizing growth factors and other bioactive molecules, Podholding's technology aims to improve clinical outcomes and patient quality of life. The company operates with a focus on commercializing these proprietary delivery systems through strategic partnerships and direct healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Podholding.